Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Successful treatment with anti-CC chemokine receptor 4 MoAb of relapsed adult T-cell leukemia/lymphoma after umbilical cord blood transplantation.

Literature DB >> 23292237

Successful treatment with anti-CC chemokine receptor 4 MoAb of relapsed adult T-cell leukemia/lymphoma after umbilical cord blood transplantation.

Y Ito, T Miyamoto, Y Chong, T Aoki, K Kato, K Akashi, T Kamimura.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2013 PMID： 23292237 DOI： 10.1038/bmt.2012.268

Source DB: PubMed Journal: Bone Marrow Transplant ISSN： 0268-3369 Impact factor: 5.483

Keyword Cloud
Cited

× No keyword cloud information.

10 in total

1. Administration of an anti-CC chemokine receptor 4 monoclonal antibody, mogamulizumab, before allogeneic bone marrow transplantation for adult T-cell leukemia/lymphoma.

Authors: S Haji; J Kiyasu; I Choi; Y Suehiro; K Toyoda; M Tsuda; A Takamatsu; Y Nakashima; H Miyoshi; M Shiratsuchi; S Yamasaki; N Uike; Y Abe
Journal: Bone Marrow Transplant Date: 2015-11-02 Impact factor: 5.483

2. Complete response following toxic epidermal necrolysis in relapsed adult T cell leukemia/lymphoma after haploidentical stem cell transplantation.

Authors: Satoshi Morishige; Marina Nishi; Hiroshi Saruta; Fumiko Arakawa; Yoshitaka Yamasaki; Shuki Oya; Takayuki Nakamura; Ritsuko Seki; Maki Yamaguchi; Kazutoshi Aoyama; Fumihiko Mouri; Koichi Osaki; Koichi Ohshima; Koji Nagafuji
Journal: Int J Hematol Date: 2019-05-31 Impact factor: 2.490

Review 3. Striving to cure adult T-cell leukaemia/lymphoma: a role for allogeneic stem cell transplant?

Authors: E H Phillips; A Hodson; O Hermine; A Bazarbachi; K Cwynarski
Journal: Bone Marrow Transplant Date: 2016-09-12 Impact factor: 5.483

4. Persistent complete remission of acute leukemic-phase CCR4-positive gamma-delta peripheral T-cell lymphoma by autologous stem cell transplantation with mogamulizumab.

Authors: Miki Furukawa; Kazuhiko Ikeda; Hiroshi Ohkawara; Shunichi Saito; Hiroshi Takahashi; Koki Ueda; Hayato Matsumoto; Yuko Hashimoto; Hitoshi Ohto; Kazuei Ogawa; Yasuchika Takeishi
Journal: Int J Hematol Date: 2015-05-15 Impact factor: 2.319

5. Safety and efficacy of mogamulizumab in patients with adult T-cell leukemia-lymphoma in Japan: interim results of postmarketing all-case surveillance.

Authors: Kenji Ishitsuka; Satoshi Yurimoto; Kouichi Kawamura; Yukie Tsuji; Manabu Iwabuchi; Takeshi Takahashi; Kensei Tobinai
Journal: Int J Hematol Date: 2017-06-09 Impact factor: 2.319

6. Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry.

Authors: Catalina Amador; Timothy C Greiner; Tayla B Heavican; Lynette M Smith; Karen Tatiana Galvis; Waseem Lone; Alyssa Bouska; Francesco D'Amore; Martin Bjerregaard Pedersen; Stefano Pileri; Claudio Agostinelli; Andrew L Feldman; Andreas Rosenwald; German Ott; Anja Mottok; Kerry J Savage; Laurence de Leval; Philippe Gaulard; Soon Thye Lim; Choon Kiat Ong; Sarah L Ondrejka; Joo Song; Elias Campo; Elaine S Jaffe; Louis M Staudt; Lisa M Rimsza; Julie Vose; Dennis D Weisenburger; Wing C Chan; Javeed Iqbal
Journal: Blood Date: 2019-12-12 Impact factor: 25.476

7. Successful treatment of a patient with adult T cell leukemia/lymphoma using anti-CC chemokine receptor 4 monoclonal antibody mogamulizumab followed by allogeneic hematopoietic stem cell transplantation.

Authors: Kenji Motohashi; Taisei Suzuki; Kumiko Kishimoto; Ayumi Numata; Yuki Nakajima; Takayoshi Tachibana; Rika Ohshima; Hideyuki Kuwabara; Masatsugu Tanaka; Naoto Tomita; Yoshiaki Ishigatsubo; Shin Fujisawa
Journal: Int J Hematol Date: 2013-06-26 Impact factor: 2.319